Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-53.48	-73.72	158.48
Graham Fair Price	237.67	0.99	0.29
PEG	-99.52	0.02	-3.84
Price/Book	-11.44	3.58	4.04
Price/Cash Flow	1156.83	-1491.09	118.64
Prices/Earnings	-92.69	-23.90	326.80
Price/Sales	76.18	21.12	11.99
Price/FCF	1156.83	-1491.09	118.64
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-8.79	0.21	0.23
Operating Margin	650.68	-0.23	0.03
ROA	1097.70	-0.02	< 0.005
ROE	< 0.005	-0.04	1110.74
ROIC	< 0.005	-0.04	1109.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	10.95	-0.84	1200.67
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.44	-4.64	-954.64
EPS QOQ	-0.85	-12.85	-1409.40
FCF QOQ	0.72	-1.07	47.32
Revenue QOQ	-0.10	-0.52	-440.15
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	100.38	219.79	118.96
Days Sales Outstanding (DSO)	116.60	202.25	73.45
Inventory Turnover	0.90	0.41	-54.33
Debt/Capitalization	< 0.005	0.07	1054.99
Quick Ratio	1.52	1.40	-7.90
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.11	1.08	-2.96
Cash	0.41	0.42	1.77
Capex	< 0.005	< 0.005	-51.84
Free Cash Flow	0.04	< 0.005	-93.16
Revenue	0.37	0.18	-51.22
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.08	2.03	-2.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-12.21	5.79	-52.60
Naive Interpretation	Member

06 - Financial Health · Bad

Rating